Results 111 to 120 of about 49,137 (244)
Safety and Feasibility of Magnetic Separation‐Based Blood Purification
We present the preclinical biological safety and translational feasibility of a magnetic nanoparticle‐based extracorporeal blood purification platform for removal of disease‐causing blood factors. ISO 10993‐compliant studies and exaggerated worst‐case exposure models demonstrate efficient nanoparticle extraction (≥99.9%), favorable biocompatibility ...
Carlos A. Mora +11 more
wiley +1 more source
Different patterns of activated partial thromboplastin time (APTT) clot waveforms predicting the presence of lupus anticoagulant. [PDF]
Ebisawa K +3 more
europepmc +1 more source
ABSTRACT Cavitary lung lesions are commonly attributed to infection; however, malignancy should remain a diagnostic consideration. We report a 30‐year‐old non‐smoking man with a history of treated Hodgkin lymphoma who presented with a cavitary pulmonary adenocarcinoma. This case highlights the importance of considering rare malignant causes.
Hosam Aldalbahi, Nora Ahmed Bedaiwi
wiley +1 more source
ABSTRACT This case highlights key laboratory red flags and a failure to respond to standard treatment, both of which should prompt urgent investigation for occult malignancy in patients presenting with cancer‐related microangiopathic hemolytic anemia (CR‐MAHA).
Danijela Jovanovic +4 more
wiley +1 more source
Factors Associated With Discordance Between the Activated Partial Thromboplastin Time and Anti-factor Xa Activity During Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study. [PDF]
Simms B, Carmona C, Karam O.
europepmc +1 more source
ABSTRACT An 18‐year‐old male had persistent tachycardia after blunt abdominal trauma. CT signs raised suspicion of main pancreatic duct disruption in the tail (suspected AAST Grade III). Exploratory laparotomy confirmed ductal transection, managed by spleen‐preserving distal pancreatectomy.
Syeda Sarah Kazmi +7 more
wiley +1 more source
Case Report: Differential diagnosis and clinical management of isolated prolonged activated partial thromboplastin time. [PDF]
Liu L, Guo D.
europepmc +1 more source
Abstract UKALL14 (NCT01085617) T‐cell arm was a phase 3, randomized‐controlled trial. Adults aged 25–65 years were randomized 1:1 at entry to receive standard of care (SOC) or SOC + nelarabine 1.5 g/m2 (Days 1, 3, and 5) to be administered following second induction. The primary end‐point was event‐free survival (EFS).
Clare J. Rowntree +14 more
wiley +1 more source
Is activated partial thromboplastin time prolongation an independent predictor of bleeding in patients with Kyasanur Forest Disease? A retrospective cohort study from southern India. [PDF]
Gupta N +5 more
europepmc +1 more source

